Medications
Tim Ferriss's first-person medication list: febuxostat (Uloric) for uric acid and Nexlizet for lipids given family cardiovascular history (September 2025), over-the-counter famotidine (Pepcid) for experimental reasons he described, Repatha, which he named in January 2026, and the sleep medicine Belsomra (suvorexant), which he said in July 2026 he takes mostly because Alzheimer's runs in his family and cycles on and off because of morning grogginess. He has not stated doses. Ferriss explicitly warned listeners not to copy these choices and to involve their doctors.
Interventions
Medications
- Ezetimibe and bempedoic acidNexlizetWhy they use it
lipid biomarkers in the context of family cardiovascular risk
Details & sources
- Famotidine (Pepcid)PepcidWhy they use it
possible anti-COVID application and possible vagal-tone effects, as described by Ferriss
Details & sources
- BelsomraWhy they use it
mostly because Alzheimer's runs in his family; he said it helps his sleep
Details & sources
Sources
Original accounts behind this protocol, with the interventions each source supports.
- Q&A with Tim — Supplements I'm Taking, AI Craziness, Dating, Training, and More ↗Uloric (febuxostat) · Nexlizet (ezetimibe and bempedoic acid) · Famotidine (Pepcid)
- How to Use Ketosis for Enhanced Mood, Cognition, and Long-Term Brain Protection — with Dr. Dominic D’Agostino (#845) transcript ↗Nexlizet (ezetimibe and bempedoic acid) · Repatha
- Dr. Andrew Huberman — Peptides, Performance, and Protocols (#876) transcript ↗Belsomra
Uloric, Nexlizet and famotidine are from the 10 September 2025 roll call; Repatha and the remark that Nexlizet might become redundant are from 7 January 2026; Belsomra is from July 2026 (#876). No source states a dose for any of them.